OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice
Mingtang Zeng, Zijing Ruan, Jia-Xi Tang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Mingtang Zeng, Zijing Ruan, Jia-Xi Tang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Showing 15 citing articles:
Nanozyme-Based Cancer Nanotheranostics: Emerging Applications and Challenges in Brain Cancer Therapeutics
Alexandra A.P. Mansur, Herman S. Mansur
Journal of Nanotheranostics (2025) Vol. 6, Iss. 1, pp. 4-4
Open Access | Times Cited: 2
Alexandra A.P. Mansur, Herman S. Mansur
Journal of Nanotheranostics (2025) Vol. 6, Iss. 1, pp. 4-4
Open Access | Times Cited: 2
Optimizing Xenograft Models for Breast Cancer: A Comparative Analysis of Cell-Derived and Patient-Derived Implantation Techniques in Pre-Clinical Research
Astrid Feinisa Khairani, Shella Harmonia, Yoan Chou, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 1-10
Open Access | Times Cited: 1
Astrid Feinisa Khairani, Shella Harmonia, Yoan Chou, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 1-10
Open Access | Times Cited: 1
Organoid: Bridging the gap between basic research and clinical practice
Guihu Weng, Jinxin Tao, Yueze Liu, et al.
Cancer Letters (2023) Vol. 572, pp. 216353-216353
Closed Access | Times Cited: 16
Guihu Weng, Jinxin Tao, Yueze Liu, et al.
Cancer Letters (2023) Vol. 572, pp. 216353-216353
Closed Access | Times Cited: 16
Unlocking the potential of the tumor microenvironment for cancer therapy
Muhammad Tufail
Pathology - Research and Practice (2023) Vol. 251, pp. 154846-154846
Closed Access | Times Cited: 10
Muhammad Tufail
Pathology - Research and Practice (2023) Vol. 251, pp. 154846-154846
Closed Access | Times Cited: 10
Patient-derived xenograft models: Current status, challenges, and innovations in cancer research
Min Liu, Xiaoping Yang
Genes & Diseases (2025), pp. 101520-101520
Open Access
Min Liu, Xiaoping Yang
Genes & Diseases (2025), pp. 101520-101520
Open Access
Cancer research revolutionized: Unveiling the power of organoids and their therapeutic potential in oncology
Yingxin Zhang, Ming Liu, Xie Na, et al.
hLife (2024)
Open Access | Times Cited: 3
Yingxin Zhang, Ming Liu, Xie Na, et al.
hLife (2024)
Open Access | Times Cited: 3
A Simple, Rapid, and Effective Method for Tumor Xenotransplantation Analysis in Transparent Zebrafish Embryos
Monika Verma, Michele Rhodes, Susan A. Shinton, et al.
Journal of Visualized Experiments (2024), Iss. 209
Open Access | Times Cited: 1
Monika Verma, Michele Rhodes, Susan A. Shinton, et al.
Journal of Visualized Experiments (2024), Iss. 209
Open Access | Times Cited: 1
Utility of patient-derived xenografts to evaluate drug sensitivity and select optimal treatments for individual non-small-cell lung cancer patients
Xiaoqing Wang, Ju Zhu, Lingling Li, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Xiaoqing Wang, Ju Zhu, Lingling Li, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Utility of patient-derived xenografts to evaluate drug sensitivity and select optimal treatments for individual non-small-cell lung cancer patients
Lanxiang Wu, Xiaoqing Wang, Ju Zhu, et al.
Research Square (Research Square) (2024)
Open Access
Lanxiang Wu, Xiaoqing Wang, Ju Zhu, et al.
Research Square (Research Square) (2024)
Open Access
Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway
Weifeng Xia, Xiaoli Zheng, Wenyi Liu, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 778-789
Closed Access
Weifeng Xia, Xiaoli Zheng, Wenyi Liu, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 778-789
Closed Access
Patientenabgeleitete 3-D-Tumormodelle
Ivona Mateska, Daniel E. Stange, Claudia R. Ball
Deleted Journal (2024)
Closed Access
Ivona Mateska, Daniel E. Stange, Claudia R. Ball
Deleted Journal (2024)
Closed Access
Unwanted disorders and xenogeneic graft‐versus‐host disease in experimental immunodeficient mice: How to evaluate and how to report
Seyed Mostafa Monzavi, Samad Muhammadnejad, Vahid Mansouri, et al.
Animal Models and Experimental Medicine (2024)
Open Access
Seyed Mostafa Monzavi, Samad Muhammadnejad, Vahid Mansouri, et al.
Animal Models and Experimental Medicine (2024)
Open Access
Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts)
Tatiana Hernández‐Guerrero, Natalia Baños, Laura del Puerto Nevado, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5402-5402
Open Access
Tatiana Hernández‐Guerrero, Natalia Baños, Laura del Puerto Nevado, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5402-5402
Open Access
Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway
Lanxiang Wu, Weifeng Xia, Xiaoli Zheng, et al.
Research Square (Research Square) (2023)
Open Access
Lanxiang Wu, Weifeng Xia, Xiaoli Zheng, et al.
Research Square (Research Square) (2023)
Open Access
Development of experimental mouse xenograft models of human tumors for preclinical in vivo studies of product for cellular immunotherapy
Julia Lopatnikova, Julia Shevchenko, J.G. Filippova, et al.
Immunologiya (2023) Vol. 44, Iss. 6, pp. 709-720
Open Access
Julia Lopatnikova, Julia Shevchenko, J.G. Filippova, et al.
Immunologiya (2023) Vol. 44, Iss. 6, pp. 709-720
Open Access
